Last updated at 14 Aug 2024 06:37 AM
Director
DIN: 09857594
Mohammad Wasim Akram is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at BLUELINE HEALTHCARE SYSTEM PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09857594.Mohammad Wasim Akram is currently involved in 2 different roles. Their most recent position is with ALFINE REMEDIES PRIVATE LIMITED as a Director. The first company Mohammad Wasim Akram was appointed to as a director was BLUELINE HEALTHCARE SYSTEM PRIVATE LIMITED. Mohammad Wasim Akram is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Mohammad Wasim Akram is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at BLUELINE HEALTHCARE SYSTEM PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09857594.Mohammad Wasim Akram is currently involved in 2 different roles. Their most recent position is with ALFINE REMEDIES PRIVATE LIMITED as a Director. The first company Mohammad Wasim Akram was appointed to as a director was BLUELINE HEALTHCARE SYSTEM PRIVATE LIMITED. Mohammad Wasim Akram is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
7 Months 4 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| BLUELINE HEALTHCARE SYSTEM PRIVATE LIMITED | Director | 11-Jan-2023 |
| BLUELINE HEALTHCARE SYSTEM PRIVATE LIMITED | Individual Promoter | 11-Jan-2023 |
| ALFINE REMEDIES PRIVATE LIMITED | Director | 03-Apr-2024 |